Singapore markets closed
Straits Times Index
3,191.36 +36.67 (+1.16%) S&P 500
5,022.21 -29.20 (-0.58%) Dow
37,753.31 -45.66 (-0.12%) Nasdaq
15,683.37 -181.88 (-1.15%) Bitcoin USD
61,425.07 -2,008.91 (-3.17%) CMC Crypto 200
885.54 0.00 (0.00%)
scPharmaceuticals Inc. (2SX.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:43AM CEST. Market open.
| Previous close | 4.1800 |
| Open | 4.1000 |
| Bid | 4.1200 x 0 |
| Ask | 4.1800 x 0 |
| Day's range | 4.1000 - 4.1000 |
| 52-week range | 4.1000 - 11.2000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 147.823M |
| Beta (5Y monthly) | 0.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%
scPharmaceuticals Inc. ( NASDAQ:SCPH ) shareholders might be concerned after seeing the share price drop 23% in the...
- Insider Monkey
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript March 13, 2024 scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48. SCPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to scPharmaceuticals Fourth Quarter and […]
- GuruFocus.com
scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth
Sequential Revenue Growth and R&D Advancements Mark Year-End Highlights
© 2024 Yahoo. All rights reserved.